<VariationArchive VariationID="632527" VariationName="NM_000067.3(CA2):c.681del (p.Lys227fs)" VariationType="Deletion" Accession="VCV000632527" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="620306" VariationID="632527">
      <GeneList>
        <Gene Symbol="CA2" FullName="carbonic anhydrase 2" GeneID="760" HGNC_ID="HGNC:1373" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="85464007" stop="85481493" display_start="85464007" display_stop="85481493" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="86376130" stop="86393720" display_start="86376130" display_stop="86393720" Strand="+" />
          </Location>
          <OMIM>611492</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000067.3(CA2):c.681del (p.Lys227fs)</Name>
      <CanonicalSPDI>NC_000008.11:85480684:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="85480685" stop="85480685" display_start="85480685" display_stop="85480685" variantLength="1" positionVCF="85480684" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="86392914" stop="86392914" display_start="86392914" display_stop="86392914" variantLength="1" positionVCF="86392913" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K227fs</ProteinChange>
      <ProteinChange>K126fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.86392916del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.86392916del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.85480687del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.85480687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007287.1" sequenceAccession="NG_007287" sequenceVersion="1" change="g.21671del">
            <Expression>NG_007287.1:g.21671del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000067.3" sequenceAccession="NM_000067" sequenceVersion="3" change="c.681del" MANESelect="true">
            <Expression>NM_000067.3:c.681del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000058.1" sequenceAccession="NP_000058" sequenceVersion="1" change="p.Lys227fs">
            <Expression>NP_000058.1:p.Lys227fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293675.2" sequenceAccession="NM_001293675" sequenceVersion="2" change="c.378del">
            <Expression>NM_001293675.2:c.378del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280604.1" sequenceAccession="NP_001280604" sequenceVersion="1" change="p.Lys126fs">
            <Expression>NP_001280604.1:p.Lys126fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000067.2" sequenceAccession="NM_000067" sequenceVersion="2" change="c.681del">
            <Expression>NM_000067.2:c.681del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="779869368" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000067.3(CA2):c.681del (p.Lys227fs) AND Osteopetrosis with renal tubular acidosis" Accession="RCV000779564" Version="7">
        <ClassifiedConditionList TraitSetID="241">
          <ClassifiedCondition DB="MedGen" ID="C0345407">Osteopetrosis with renal tubular acidosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-06-30" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000067.3(CA2):c.681del (p.Lys227fs) AND not provided" Accession="RCV001873184" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-06" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15300855</ID>
        </Citation>
        <DescriptionHistory Dated="2021-07-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="241" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3688" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive osteopetrosis type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteopetrosis with renal tubular acidosis</ElementValue>
                <XRef ID="Osteopetrosis+autosomal+recessive+3/5479" DB="Genetic Alliance" />
                <XRef ID="254122007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Guibaud Vainsel syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marble brain disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carbonic anhydrase 2 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteopetrosis, autosomal recessive 3, with renal tubular acidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OPTB3</ElementValue>
                <XRef Type="MIM" ID="259730" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4154" />
                <XRef ID="4154" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2785" DB="Orphanet" />
              <XRef ID="C0345407" DB="MedGen" />
              <XRef ID="MONDO:0009818" DB="MONDO" />
              <XRef Type="MIM" ID="259730" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1791317" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="906722" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000916238" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8128957</ID>
          </Citation>
          <Comment>The CA2 c.681delA (p.Lys227AsnfsTer13) variant is a frameshift variant that is predicted to cause premature truncation of the protein. The p.Lys227AsnfsTer13 variant has been reported in one study and is found in a homozygous state in seven unrelated individuals diagnosed with osteopetrosis with renal tubular acidosis (Hu et al. 1994). Control data are unavailable for this variant and it is reported at a frequency of 0.00009 in the Latino population of the Exome Aggregation Consortium but this is based on one allele only in a region of good sequencing coverage so the variant is presumed to be rare. The p.Lys227AsnfsTer13 variant when expressed in COS cells produced an enzymatically inactive protein that was expressed at much lower levels than wild type protein (Hu et al. 1994). Based on the evidence and the potential impact of frameshift variants, the p.Lys227AsnfsTer13 variant is classified as likely pathogenic for osteopetrosis with renal tubular acidosis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="8" alternateAllele="T" referenceAllele="TA" start="86392913" stop="86392914" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000067.2:c.681delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="259730" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3447921" SubmissionDate="2021-07-09" DateLastUpdated="2021-07-18" DateCreated="2021-07-18">
        <ClinVarSubmissionID localKey="NM_000067.2:c.681del|OMIM:259730" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001752445" DateUpdated="2021-07-18" DateCreated="2021-07-18" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000067.2:c.681del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="259730" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>This variant has been detected in individual(s) who were sent for testing of Renasight - kidney gene panel.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB9977930</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7337039" SubmissionDate="2023-05-17" DateLastUpdated="2023-05-20" DateCreated="2023-05-20">
        <ClinVarSubmissionID localKey="GDXSV:271877" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003925048" DateUpdated="2023-05-20" DateCreated="2023-05-20" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>In vitro published functional studies demonstrate the variant results in an inactive, insoluble, and quickly degraded enzyme (Hu et al., 1994); Frameshift variant predicted to result in protein truncation, as the last 34 amino acids are replaced with 12 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27535533, 8128957, 24077912)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CA2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:765456</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000067.2:c.681del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_191_20230517054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4221378" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="3856684|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002205939" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8128957</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8128957</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15300855</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys227Asnfs*13) in the CA2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 34 amino acid(s) of the CA2 protein. This variant is present in population databases (rs779869368, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with CA2 deficiency (PMID: 8128957). This variant is also known as a frameshift at amino acid 227, resulting in incorporation of 12 abnormal amino acids before termination at a TGA codon. ClinVar contains an entry for this variant (Variation ID: 632527). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects CA2 function (PMID: 8128957). This variant disrupts a region of the CA2 protein in which other variant(s) (p.Glu233Glyfs*2) have been observed in individuals with CA2-related conditions (PMID: 15300855). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.86392914del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1791317" TraitType="Disease" MappingType="XRef" MappingValue="259730" MappingRef="OMIM">
        <MedGen CUI="C0345407" Name="Osteopetrosis with renal tubular acidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4221378" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7337039" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3447921" TraitType="Disease" MappingType="XRef" MappingValue="259730" MappingRef="OMIM">
        <MedGen CUI="C0345407" Name="Osteopetrosis with renal tubular acidosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

